APLM Apollomics Inc - Ordinary Shares - Class A
1,436
$0.298
$0.0088
(2.87%)
| Watchers | 1,436 |
| 52-Wk Low | $0.2314 |
| 52-Wk High | $6.20 |
| Market Cap | $26.67M |
| Volume | 640,977.00 |
| 52-Wk High | $6.20 |
| 52-Wk Low | $0.2314 |
Analysts Offer Insights on Healthcare Companies: CalciMedica (CALC), Apollomics (APLM) and Iterum Therapeutics (ITRM)TipRanks Financial Blog • 2 months ago
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CalciMedica (CALC Research Report), Apollomics (AP...
Share to Feed
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Continued clinical and regulatory progress for the vebreltinib (APL-101) registration-enabling programCompleted patient enrollment for the uproleselan (APL-106) Phase 3 bridging study in China...
Apollomics, Inc. (APLM) Q4 2023 Earnings Call Transcript...
Apollomics, Inc. (APLM) Q4 2023 Earnings Call Transcript...
Apollomics, Inc. (NASDAQ:APLM Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 43,900 shares, an...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Apollomics receives Nasdaq notification regarding minimum bid price deficiency...
Apollomics has an initial 180-day period through July 15, 2024 to regain compliance with Minimum Bid Price RequirementFOSTER CITY, Calif., Jan. 19, 2024 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq...